The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

(2014) Luca Faloppi et al.   BMC CANCER

Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis

(2014) Nicola Silvestris et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients

(2013) Mario Scartozzi et al.   PHARMACOGENOMICS

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

(2012) M Scartozzi et al.   BRITISH JOURNAL OF CANCER

Biliary tract carcinomas: From chemotherapy to targeted therapy

(2012) Donatella Marino et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management

(2012) Mario Scartozzi et al.   PLoS One

Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer

(2011) G. K. Siddiqui et al.   ANGIOGENESIS

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma

(2009) Armin Thelen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intrahepatic Cholangiocarcinoma

(2009) Itaru Endo et al.   ANNALS OF SURGERY

Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells

(2009) D L Roberts et al.   BRITISH JOURNAL OF CANCER

A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer

(2009) Junji Furuse et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling

(2008) R Tsuchida et al.   ONCOGENE